Search & Analyze

Nephrocare Health Services Ltd.

609.20−21.15 (−3.36%)

BSE · 30 Oct, 4:01 PM

: ₹6,193.93 Cr
: 80.61
: 4,381
: ₹628.25 - ₹608.75
: ₹781.00 - ₹445.00

Nephrocare Health Services Ltd. (NEPHROPLUS) share price closed at ₹609.20 on the BSE on Friday, October 30, 2026, down by 3.36% from its of ₹630.35. In that session NEPHROPLUS reached a of 628.25 and of 608.75. The for the session was 620.77. The stands at 673.64 and is at 617.50. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹624.75

₹630.35

₹620.77

₹673.64

Price 9.57% below

₹617.50

Price 1.34% below

Key Fundamentals

: 6,193.93 Cr₹6.19 Thousand Crore
: 7.64
: 80.61
: 5.46
: 112.78
: 251.48 Cr₹251.48 Crore
: 0.00 %
Sector
Industry: Hospital & Healthcare Services
: 9.22
: 0.02

Industry Comparison

Ratio	Company	Sector
	80.61	44.77
	0.02	0.20
	5.46	4.61
	2.80	1.81
	0.00 %	0.11 %
Operating Margin	22.72 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,400.00	57.80	1,20,779.11	0.24	610.40	38.41%	7,043.50	20.56%	21.73
MANIPALHOS MANIPALHOS	668.45	98.54	87,926.39	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
MAXHEALTH MAXHEALTH	860.00	60.63	83,706.13	0.23	414.45	-15.64%	2,569.21	20.31%	14.97
ASTERDM ASTERDM	680.40	186.93	59,308.59	0.44	29.28	-68.70%	1,310.68	21.60%	16.22
FORTIS FORTIS	769.80	55.46	58,116.68	0.13	272.80	2.26%	2,545.03	17.46%	14.07
NH NH	1,700.00	43.06	34,741.34	0.26	301.15	16.50%	2,843.99	73.01%	16.20
MEDANTA MEDANTA	1,265.00	61.35	34,013.01	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
Nephrocare Health Services Ltd. NEPHROPLUS	609.20	80.61	6,193.93	0.00	31.97	34.89%	281.75	23.69%	16.18

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Dec 2024	Mar 2025	Jun 2025	Dec 2025	Mar 2026	Jun 2026
	197.26	219.19	227.78	259.73	265.62	281.75
Expenses	153.16	167.89	180.22	198.86	211.85	217.87
	44.09	51.30	47.57	60.87	53.77	63.88
	22.35%	23.40%	20.88%	23.43%	20.24%	22.67%
	5.37	4.11	6.58	3.32	11.57	7.46
Interest	4.85	6.12	6.10	5.96	3.18	2.21
	18.17	19.38	19.52	21.86	25.85	24.54
	26.44	29.92	28.52	36.36	33.22	41.03
	23.93%	16.89%	16.88%	11.33%	8.58%	22.07%
	20.11	24.87	23.70	32.24	30.37	31.97
	114.00	28.18	13.10	3.21	3.03	3.19

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME:
Operating Income	437.30	566.16	755.81	998.85
Operating Income (Net)	437.30	566.16	755.81	998.85
EXPENDITURE :
Cost of Medicines and Consumables	142.51	168.61	194.14	226.79
Power & Fuel Cost	13.26	14.84	20.51	24.70
Employee Cost	96.69	91.39	122.66	171.79
Hospital Operation Expenses	94.34	135.06	188.42	245.46
Selling, Administration and Other Expenses	28.82	34.63	44.90	68.24
Miscellaneous Expenses	13.07	20.74	18.53	34.91
	388.70	465.27	589.18	771.88
Operating Profit (Excl OI)	48.59	100.89	166.64	226.96
	5.96	8.57	14.10	24.51
	54.56	109.45	180.74	251.48
Interest	16.27	20.18	20.83	60.24
PBDT	38.29	89.27	159.91	191.23
	46.88	56.11	72.47	90.67
Profit Before Taxation & Exceptional Items	-8.59	33.16	87.44	100.57
	-8.59	33.16	87.44	97.47
Provision for Tax	3.20	-1.97	20.34	20.63
	-11.79	35.13	67.10	76.84
Extra items			0.00	0.00
Consolidated Net Profit	-11.79	35.13	67.10	76.84
Profit Balance B/F	-121.99	-134.77	-96.92	-30.61
Appropriations	-133.78	-99.63	-29.82	46.23
	-67.75	200.87	380.15	7.66
Adjusted EPS	-13.55	40.18	76.03	7.66

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	5.14	5.14	5.43	20.07
Share Warrants & Outstandings	8.12	6.38	12.56	18.00
Total Reserves	375.37	402.19	566.12	1,078.43
Reserve excluding Revaluation Reserve	375.37	402.19	566.12	1,078.43
Revaluation reserve	0.00	0.00
	388.63	413.71	584.11	1,116.49
Secured Loans	81.48	123.24	96.00	0.05
Deferred Tax Assets / Liabilities	-16.65	-23.27	-18.53	-30.41
Other Long Term Liabilities	17.42	22.80	25.60	45.51
Long Term Provisions	4.09	3.32	4.82	5.86
Total Non-Current Liabilities	86.33	126.09	107.88	21.00
Trade Payables	43.28	70.53	112.88	143.01
Other Current Liabilities	38.24	78.03	63.01	124.09
Short Term Borrowings	91.64	93.01	101.11	13.23
Short Term Provisions	1.46	1.01	6.89	19.09
Total Current Liabilities	174.61	242.59	283.90	299.41
Total Liabilities	649.58	782.39	975.89	1,436.91
Gross Block	385.89	564.04	678.54	841.15
Less: Accumulated Depreciation	146.47	208.28	282.24	323.46
Less: Impairment of Assets				1.18
	239.42	355.76	396.30	516.52
	31.65	0.69	5.84	5.54
Non Current Investments				7.14
Long Term Investment	0.00	0.00		7.14
Long Term Loans & Advances	10.41	15.75	10.48	22.57
Other Non Current Assets	41.66	20.15	17.92	45.73
Total Non-Current Assets	325.32	392.35	430.54	597.74
Currents Investments			50.76	170.64
Inventories	26.27	25.91	26.62	33.04
Sundry Debtors	158.51	202.67	266.42	316.89
Cash and Bank	14.20	61.17	155.39	255.46
Other Current Assets	4.13	6.64	6.05	7.60
Short Term Loans and Advances	121.15	93.64	40.13	55.54
Total Current Assets	324.26	390.03	545.36	839.17
Net Current Assets (Including Current Investments)	149.64	147.45	261.46	539.76
Total Assets	649.58	782.39	975.89	1,436.91
Total Debt	196.21	243.37	225.80	23.02
	2,167.32	2,309.53	3,217.49	109.48
Adjusted Book Value	433.46	461.91	643.50	109.48

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
	-8.59	33.16	87.44	97.47
Adjustment	68.56	80.18	93.04	168.22
Changes In working Capital	-53.32	-33.00	-44.17	-5.64
Cash Flow after changes in Working Capital	6.65	80.34	136.30	260.06
Cash Flow from Operating Activities	11.27	72.28	135.35	232.58
Cash Flow from Investing Activities	-78.21	-50.66	-125.07	-410.44
Cash Flow from Financing Activitie	59.97	26.74	54.37	157.11
Net Cash Inflow / Outflow	-6.97	48.36	64.65	-20.75
Opening Cash & Cash Equivalents	18.55	14.06	61.15	125.82
Effect of Foreign Exchange Fluctuations	2.48	-1.27	0.02	18.82
Closing Cash & Cash Equivalent	14.06	61.15	125.82	123.89

Ratios

Valuation

80.61

5.46

23.71

6.20

7.64

112.78

Profitability

9.22

16.18

6.37

22.72

7.69

Leverage & Liquidity

0.02

2.80

2.62

Returns

0.00

0.83

Shareholding Pattern

Numbers in percentages

Particulars	Dec '25	Mar '26	Jun '26	Sep '26
	63.85	63.85	63.85	58.31
	12.27	18.59	17.83	19.84
	23.88	17.56	18.32	21.85
	36.15	36.15	36.15	41.69
No. of Shareholders	2,12,979	43,409	44,091	56,735

Mutual Funds Invested(26)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 17 active funds hold 4.10% in Nephrocare Health Services Ltd., contributing to ₹272 Cr of holdings

Fund				As of
SB SBI Healthcare Opportunities Fund - Growth - Direct PlanPharma & Health Care	65.98	1.12	10,00,000	Sep '26
DS DSP Healthcare Fund - Growth - Direct PlanPharma & Health Care	41.89	1.12	6,34,983	Sep '26
HE Helios Small Cap Fund - Growth - Direct PlanSmall cap Fund	25.16	1.33	3,81,334	Sep '26
ID Bandhan Innovation Fund - Growth - Direct PlanEquity - Thematic Fund - Other	24.02	0.78	3,64,005	Sep '26
LI LIC MF Infrastructure Fund - Growth - Direct PlanInfrastructure	23.22	2.01	3,52,000	Sep '26
ID Bandhan Small Cap Fund - Growth - Direct PlanSmall cap Fund	18.58	0.05	2,81,637	Sep '26
LI LIC MF Multi Asset Allocation Fund - Growth - Direct PlanHybrid - Multi Asset Allocation	13.26	1.37	2,01,000	Sep '26
IP ICICI Prudential Retirement Fund - Hybrid Aggressive Plan - Growth - Direct PlanEquity Oriented	12.51	0.99	1,89,672	Sep '26
LI LIC MF Value Fund - Growth - Direct PlanEquity - Value Fund	10.56	3.14	1,60,000	Sep '26
ID Bandhan Contra Fund - Growth - Direct PlanEquity - Contra Fund	8.15	0.48	1,23,565	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-12	Board Meeting	Quarterly Results
2026-07-16	AGM
2026-05-04	Board Meeting	Audited Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareHospital & Healthcare Services

Nephrocare Health Services Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Kishore Kathri

Head Legal, Company Secretary & Compliance Officer

—

Vikram Vuppala

Chairman & Managing Director

₹4.48 Cr

Mar '26

Om Prakash Manchanda

Non Executive Independent Director

₹25.00 L

Mar '26

Hemant Sultania

Non Executive Independent Director

₹25.00 L

Mar '26

Ajay Bakshi

Non Executive Independent Director

₹25.00 L

Mar '26

Vishal Vijay Gupta

Nominee Director

—

Gaurav Sharma

Nominee Director

—

Sunil Kumar Thakur

Nominee Director

—

Annette Berit Ingrid Kumlien

Non Executive Independent Director

₹25.00 L

Mar '26

NEPHROPLUS Latest News

News

10 of 10 articles

COMPANY13 Aug 2026 · 14:10

Nephrocare Health’s arm enters into Asset Transfer Agreement with Juan Nephro Dialysis Center

The agreement is for the acquisition of identified assets relating to a dialysis center located in Davao City

EQUITY23 Jun 2026 · 17:00

Nephrocare Health Services informs about updates

EQUITY11 Jun 2026 · 14:24

Nephrocare Health trades higher on the BSE

The company’ overseas step-down wholly-owned subsidiary -- Nephrocare Health Care Services, Philippines Inc., has entered into ATA with Amica Healthcare System Corporation

EQUITY10 Jun 2026 · 14:44

Nephrocare Health Services informs about updates

EQUITY10 Jun 2026 · 11:35

Nephrocare Health shines as its arm inks asset transfer pact with Amica Healthcare System Corporation

The agreement is for the acquisition of identified assets relating to a dialysis center located at Dona Soledad, Don Bosco, Paranaque City, Philippines

COMPANY10 Jun 2026 · 11:30

Nephrocare Health’s arm inks asset transfer pact with Amica Healthcare System Corporation

The agreement is for the acquisition of identified assets relating to a dialysis center located at Dona Soledad, Don Bosco, Paranaque City, Philippines

EQUITY5 Jun 2026 · 11:08

Nephrocare Health jumps as its arm inks asset transfer pact with Inocentes Dialysis Clinic

The agreement is for the acquisition of identified assets relating to a dialysis center located at Duyan-Duyan, Project 3, Quezon City, Philippines

COMPANY4 Jun 2026 · 18:05

Nephrocare Health’s arm inks asset transfer pact with Inocentes Dialysis Clinic

The agreement is for the acquisition of identified assets relating to a dialysis center located at Duyan-Duyan, Project 3, Quezon City, Philippines

EQUITY27 May 2026 · 10:10

Nephrocare Health Services rises as its arm incorporates wholly-owned subsidiary in Kazakhstan

NPHSK LLP has been incorporated with the objective of undertaking holding and management activities to expand its kidney care and dialysis services network in Kazakhstan

COMPANY27 May 2026 · 09:50

Nephrocare Health Services’ arm incorporates wholly-owned subsidiary in Kazakhstan

NPHSK LLP has been incorporated with the objective of undertaking holding and management activities to expand its kidney care and dialysis services network in Kazakhstan

Nephrocare Health Services Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(26)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

NEPHROPLUS Latest News

News